Stay updated with breaking news from Bob Lojewski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- CSL Behring, a business unit of global biotechnology leader CSL, today announced survey results showing that the majority of surveyed people...
Hizentra (immune globulin subcutaneous [human] 20% Liquid) is now available in a new 10g/50mL prefilled syringe.
By Deena Beasley (Reuters) - High cost, logistical issues and the prospect of potential treatment advances are holding back adoption of the first gene...
High cost, logistical issues and the prospect of potential treatment advances are holding back adoption of the first gene therapies for hemophilia, experts said this week during the American Society...
The FDA has approved a new 50mL/10gm prefilled syringe for Hizentra (immune globulin subcutaneous [human] 20% liquid).